These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Effect of silver on burn wound infection control and healing: review of the literature. Atiyeh BS; Costagliola M; Hayek SN; Dibo SA Burns; 2007 Mar; 33(2):139-48. PubMed ID: 17137719 [TBL] [Abstract][Full Text] [Related]
43. Bacteriological and clinical studies on sulfamylon in the treatment of burns. Rudowski W; Brudzynska-Charewicz S; Zietkiewicz W; Nasilowski W; Serafinska D; Bukowska D Br J Plast Surg; 1972 Apr; 25(2):135-40. PubMed ID: 4260061 [No Abstract] [Full Text] [Related]
44. Control of infection in the burn unit. DelVecchio AM; Dickerson EL APIC; 1978 Dec; 6(4):18-21. PubMed ID: 10239936 [No Abstract] [Full Text] [Related]
45. Glucan phosphate treatment attenuates burn-induced inflammation and improves resistance to Pseudomonas aeruginosa burn wound infection. Lyuksutova OI; Murphey ED; Toliver-Kinsky TE; Lin CY; Cui W; Williams DL; Sherwood ER Shock; 2005 Mar; 23(3):224-32. PubMed ID: 15718919 [TBL] [Abstract][Full Text] [Related]
46. Management of the acute burn patient--1973. Garrison AF; Jelenko C Postgrad Med; 1973 Aug; 54(2):43-9. PubMed ID: 4352775 [No Abstract] [Full Text] [Related]
47. Burn-induced immunological modifications. Preliminary results with levamisole. Mazzoleni F; Chiarelli A; Corsano A; Dal Lago O; Fagiolo U Acta Chir Plast; 1981; 23(2):74-81. PubMed ID: 6167094 [No Abstract] [Full Text] [Related]
48. Control of experimental and clinical burn wounds sepsis by topical application of sulfamylon compounds. Lindberg RB; Moncrief JA; Mason AD Ann N Y Acad Sci; 1968 Aug; 150(3):950-60. PubMed ID: 4973466 [No Abstract] [Full Text] [Related]
49. The use of a topical sulfonamide in the control of burn wound sepsis. Moncrief JA; Lindberg RB; Switzer WE; Pruitt BA J Trauma; 1966 May; 6(3):407-19. PubMed ID: 5934283 [No Abstract] [Full Text] [Related]
50. Burns. Infection and immunology. Munster AM; Winchurch RA Crit Care Clin; 1985 Mar; 1(1):119-27. PubMed ID: 3870967 [TBL] [Abstract][Full Text] [Related]
51. Silver sulfadiazine and Sulfamylon cream in the burned rat model: a comparative evaluation. Dressler DP; Skornik WA Surgery; 1970 Apr; 67(4):644-9. PubMed ID: 5435914 [No Abstract] [Full Text] [Related]
52. Possible deleterious effects of topical agents on the rate of healing on the burn wound. Flagg SV; Converse JM; Rapaport FT Surg Forum; 1969; 20():501-3. PubMed ID: 5383130 [No Abstract] [Full Text] [Related]
53. The epidemiology of burn wound infections: then and now. Mayhall CG Clin Infect Dis; 2003 Aug; 37(4):543-50. PubMed ID: 12905139 [TBL] [Abstract][Full Text] [Related]
55. [Problems of sulfamylon treatment for burns]. Shimazaki S; Minami T; Tanaka N; Kawasaki K; Yamada R Geka Chiryo; 1972 May; 26(5):589-95. PubMed ID: 4626291 [No Abstract] [Full Text] [Related]
56. The management of burns. I. General considerations and the sulfamylon method. Shuck JM; Moncrief JA Curr Probl Surg; 1969 Feb; ():3-52. PubMed ID: 4889510 [No Abstract] [Full Text] [Related]
57. The behavior of mafenide acetate as a basis for its clinical use. Harrison HN; Bales H; Jacoby F Arch Surg; 1971 Oct; 103(4):449-53. PubMed ID: 5094550 [No Abstract] [Full Text] [Related]
58. [Experience in the use of ofloxacin in the prevention and treatment of wound infection in burns]. Alekseev AA; Iakovlev VP; Krutikov MG; Kashin ID; Dutikov VN; Elagina LV; Izotova GN Klin Med (Mosk); 1995; 73(6):46-51. PubMed ID: 8691783 [TBL] [Abstract][Full Text] [Related]
59. [Local treatment of burns: analysis of the use of antimicrobial agents]. Mariani U; Pinto WS; Pinto DC Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(2):69-75. PubMed ID: 8235276 [TBL] [Abstract][Full Text] [Related]